CoChat

Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression

Open access
De Berardis, Domenico, Fornaro, Michele, Serroni, Nicola, Campanella, Daniela, Rapini, Gabriella, Olivieri, Luigi, Srinivasan, Venkataramanujam, Iasevoli, Felice, Tomasetti, Carmine, De Bartolomeis, Andrea, Valchera, Alessandro, Perna, Giampaolo, Mazza, Monica, Di Nicola, Marco, Martinotti, Giovanni, Di Giannantonio, Massimo · 2015 · International Journal of Molecular Sciences
Cited by 75

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Agomelatine, a melatonergic antidepressant with a rapid onset of action, is one of the most recent drugs in the antidepressant category. Agomelatine’s antidepressant actions are attributed to its sleep-promoting and chronobiotic actions mediated by MT1 and MT2 receptors present in the suprachiasmatic nucleus, as well as to its effects on the blockade of 5-HT2c receptors. Blockade of 5-HT2c receptors causes release of both noradrenaline and dopamine at the fronto-cortical dopaminergic and noradrenergic pathways. The combined actions of agomelatine on MT1/MT2 and 5-HT2c receptors facilitate the resynchronization of altered circadian rhythms and abnormal sleep patterns. Agomelatine appeared to be effective in treating major depression. Moreover, evidence exists that points out a possible efficacy of such drug in the treatment of bipolar depression, anxiety disorders, alcohol dependence, migraines etc. Thus, the aim of this narrative review was to elucidate current evidences on the role of agomelatine in disorders other than major depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms16011111

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 75

Metadata

Authors
De Berardis, D., Fornaro, M., Serroni, N., Campanella, D., Rapini, G., Olivieri, L., Srinivasan, V., Iasevoli, F., Tomasetti, C., De Bartolomeis, A., Valchera, A., Perna, G., Mazza, M., Di Nicola, M., Martinotti, G., & Di Giannantonio, M.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2015-01-05
Volume
16
Issue
1
Pages
1111-1130
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2133305361
Cited by
75
References
14
FWCI
5.29
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression. https://app.cochat.ai/papers/10.3390/ijms16011111
The paper
De Berardis, D., Fornaro, M., Serroni, N., Campanella, D., Rapini, G., Olivieri, L., Srinivasan, V., Iasevoli, F., Tomasetti, C., De Bartolomeis, A., Valchera, A., Perna, G., Mazza, M., Di Nicola, M., Martinotti, G., & Di Giannantonio, M. (2015). Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms16011111

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.